NEW YORK (GenomeWeb News) - Caliper Life Sciences said today that it has signed an agreement to sell its Pharmaceutical Development & Quality Analysis, or PDQ, product line to pharmaceutical testing firm Sotax in a deal worth around $15.8 million.
 
The sale of Caliper’s PDQ product line, which includes products for drug content uniformity and dissolution rate testing and related services, is expected to close next month.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.